Genpharmasec

  • Market Cap: Micro Cap
  • Industry: Trading & Distributors
  • ISIN: INE861N01036
  • NSEID:
  • BSEID: 531592
INR
1.15
0.02 (1.77%)
BSENSE

Jun 18

BSE+NSE Vol: 1.93 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 329838,
    "name": "Genpharmasec",
    "stock_name": "Genpharmasec",
    "full_name": "Genpharmasec Ltd",
    "name_url": "stocks-analysis/genpharmasec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1.15",
    "chg": 0.02,
    "chgp": "1.77%",
    "dir": 1,
    "prev_price": "1.13",
    "mcapval": "64.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531592,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE861N01036",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "1.93 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/genpharmasec-329838-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-3975837",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GenpharmasecLtd_mojoScore_3975837.png",
        "date": "2026-05-05 10:10:02",
        "description": "Genpharmasec Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-3960705",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GenpharmasecLtd_mojoScore_3960705.png",
        "date": "2026-04-24 10:10:03",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-3944707",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GenpharmasecLtd_mojoScore_3944707.png",
        "date": "2026-04-13 10:10:03",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 13 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-3930273",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GenpharmasecLtd_mojoScore_3930273.png",
        "date": "2026-04-02 10:10:03",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 02 April 2026, providing investors with the latest comprehensive view of the company’s position."
      }
    ],
    "total": 14,
    "sid": "329838",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/genpharmasec-329838"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "27-May-2026",
      "details": "Annual Secretarial Compliance Report for the year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "23-May-2026",
      "details": "Newspaper Publication of Audited Financial Result for the quarter and year ended 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Thursday May 21 2026.",
      "datetime": "21-May-2026",
      "details": "Outcome of the Meeting of Board of Directors held on Thursday May 21 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Apr 19",
          "dt": "2019-04-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:1</strong> rights issue, ex-date: 09 Jan 24",
          "dt": "2024-01-09",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Compliances-Reg.24(A)-Annual Secretarial Compliance

27-May-2026 | Source : BSE

Annual Secretarial Compliance Report for the year ended March 31 2026.

Announcement under Regulation 30 (LODR)-Newspaper Publication

23-May-2026 | Source : BSE

Newspaper Publication of Audited Financial Result for the quarter and year ended 31st March 2026.

Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Thursday May 21 2026.

21-May-2026 | Source : BSE

Outcome of the Meeting of Board of Directors held on Thursday May 21 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Genpharmasec Ltd has announced 1:10 stock split, ex-date: 11 Apr 19

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Genpharmasec Ltd has announced 1:1 rights issue, ex-date: 09 Jan 24